WASHINGTON--(BUSINESS WIRE)--Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the Hatch-Waxman Integrity Act of 2018: “For almost ...
WASHINGTON--(BUSINESS WIRE)--BIO President and CEO Jim Greenwood issued the following statement regarding today’s proposed changes to Medicare Part D and Medicare Advantage plans: “Today’s proposed ...
BIO Statement on Confirmation of von Eschenbach as FDA Commissioner WASHINGTON, Dec. 7 -- Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), issued the following ...
WASHINGTON -- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the Qualifying Therapeutic Discovery Project Tax Credit Extension Act ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback